Vident Advisory »

Orchard Therapeutics shares owned by Vident Advisory

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by Vident Advisory from 13F filings

Historical chart of Vident Advisory investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by Vident Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by Vident Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $185k 11k 16.45

More positions owned by Vident Advisory

Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Home Depot (HD)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Apple (AAPL)
Cisco Systems (CSCO)
Abbvie (ABBV)
Cameco Corporation (CCJ)
Etf Ser Solutions Vident Us Equity (VUSE)
Metropcs Communications (TMUS)
Applied Materials (AMAT)
Bristol Myers Squibb (BMY)
Comcast Corp Cl A (CMCSA)

View all positions for Vident Advisory

Top funds holding Orchard Therapeutics

Blue Owl Capital Holdings
Beryl Capital Management
Federated Investors
LMR Partners
Tudor Investment Corporation
Millennium Management
Goldman Sachs Group
CSS
ADAR1 Capital Management
Bck Capital Management
Jane Street
Jpmorgan Chase & Co
Hrt Financial
PenderFund Capital Management
Gts Securities

View all funds holding Orchard Therapeutics